High-Impact Form 4 Intelligence
Real-time SEC insider trading data with advanced filtering. Free beta.
Total Buys (Filtered)
$0
$0
Total Sells (Filtered)
$2.0M
$2,017,179
| Ticker | Company | Reporting Owner | Date | Value (USD) | Type | Form 4 |
|---|---|---|---|---|---|---|
|
RYTM
M
RHYTHM PHARMACEUTICALS, INC.
German Christopher Paul
• Officer • Corporate Controller & CAO
Other
2026-03-04
$26,955
|
||||||
| RYTM |
RHYTHM PHARMACEUTICALS, INC.
|
Officer • Corporate Controller & CAO
Other
|
2026-03-04 | $26,955 | M | Form 4 |
|
RYTM
S
RHYTHM PHARMACEUTICALS, INC.
German Christopher Paul
• Officer • Corporate Controller & CAO
Discretionary SellΔOwn -97.2%
2026-03-04
$502,790
|
||||||
| RYTM |
RHYTHM PHARMACEUTICALS, INC.
|
Officer • Corporate Controller & CAO
Discretionary SellΔOwn -97.2%
|
2026-03-04 | $502,790 | S | Form 4 |
| RYTM |
RHYTHM PHARMACEUTICALS, INC.
|
CFO
Other
|
2026-03-02 | $41,473 | M | Form 4 |
| RYTM |
RHYTHM PHARMACEUTICALS, INC.
|
CFO
10b5-1 Sell
|
2026-02-19 | $444,004x4 | S | Form 4 |
| RYTM |
RHYTHM PHARMACEUTICALS, INC.
|
CFO
10b5-1 Sell
|
2026-02-17 | $361,810x5 | S | Form 4 |
| RYTM |
RHYTHM PHARMACEUTICALS, INC.
|
CFO
10b5-1 Sell
|
2026-02-12 | $156,380x4 | S | Form 4 |
| RYTM |
RHYTHM PHARMACEUTICALS, INC.
|
CFO
10b5-1 Sell
|
2026-02-11 | $272,766x3 | S | Form 4 |
| RYTM |
RHYTHM PHARMACEUTICALS, INC.
|
CFO
10b5-1 Sell
|
2026-02-10 | $279,429x3 | S | Form 4 |